Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health topic
No spam. Unsubscribe anytime.
Budget committee forwards DPH contract extensions and multiple grant acceptances totaling millions
Summary
DPH presented a package of contract amendments and retroactive grant acceptances: Community Forward medical respite and sobering center amendment (~$32.26M), Bayview Hunters Point Foundation amendment (~$25.6M), and multiple grants including Housing and Homelessness Incentive awards and CDC/NIH HIV prevention grants. The committee forwarded the items, some with clerical corrections; one contract was forwarded without recommendation due to prior controller tier-3 status.
The committee considered several Department of Public Health items on Dec. 10 and moved them to the full Board for consideration.
Item 7: DPH requested an amendment with Community Forward San Francisco to continue medical respite, sobering center and a managed alcohol program. Dara Pappo said the program comprises 75 medical-respite beds (including 10 managed-alcohol beds) and a 14-bed sobering center; the amendment increases the contractual not-to-exceed amount to approximately $32.26 million and extends the term through June 30, 2029. The BLA recommended approval.
Item 8: DPH requested an amendment with Bayview Hunters Point Foundation to extend outpatient behavioral-health contracts and increase the value to approximately $25.6 million through June 30, 2028. DPH said the provider had been on controller tier-3 status but has met corrective-action items for cash-flow stabilization and invoicing accuracy; outstanding audit items remain under resolution. The committee forwarded the amendment to the full Board without recommendation, with monitoring recommended.
Items 9—2: DPH sought retroactive authorization to accept and expend several grants including Housing and Homelessness Incentive Program funds (combined awards referenced in presentations at approximately $3.144 million), a CDC Integrated HIV Prevention and Surveillance grant (annual funding levels discussed, with an initial year award and subsequent $7.0M annual levels), and an NIH/ATN increase for BRIDGE HIV (~$62,000 increase to $235,000 total) to support prevention, surveillance, and clinical-trials leadership. Presenters emphasized the grants support integrated prevention, surveillance, and community partners including jail health and city clinics. The committee forwarded the set of grants to the full Board with recommendation (3-0).
No public speakers were recorded for these items; committee members requested photos and site details for future DPH presentations and discussed continued monitoring for providers with prior fiscal concerns.
